Effects of metronidazole and oligofructose on faecal concentrations of sulphate-reducing bacteria and their activity in human volunteers

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 11, 2005, Pages 1296-1303

  Lewis, Stephen ^a   Brazier, Jon ^b   Beard, David ^b   Nazem, Naeem ^b   Proctor, Douglas ^b  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Bifidobacteria; Oligofructose; Prebiotic; Sulphate reducing bacteria

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; HYDROGEN SULFIDE; LACTIC ACID; METRONIDAZOLE; OLIGOFRUCTOSE; OLIGOSACCHARIDE; PENICILLIN DERIVATIVE; PREBIOTIC AGENT; RAFTILOSE; SHORT CHAIN FATTY ACID; SULFATE; SULFIDE; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FECES ANALYSIS; FECES CULTURE; FEMALE; GAS LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MICROBIAL ACTIVITY; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SULFATE REDUCING BACTERIUM; ULCERATIVE COLITIS;

ADULT; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FECES; FEMALE; HUMANS; MALE; METRONIDAZOLE; OLIGOSACCHARIDES; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SULFUR-REDUCING BACTERIA;

EID: 27844458542     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520510023585     Document Type: Article

References (38)

1. Pitcher MCL, Cummings JH. Hydrogen sulphide: a bacterial toxin in ulcerative colitis. Gut 1996;39:1-4.
2. Smith L, Kryszyna H, Smith RP. The effect of methaemoglobin on the inhibition of cytochrome c oxidase by cyanide, sulfide or azide. Biochem Pharmacol 1977;22:47-50.
3. Florin THJ, Neale G, Cummings JH. The effect of hydrogen sulphide on isolated colonic epithelium. Inflammatory bowel disease-progress in basic research and clinical implications. Falk Symp 1990;60:26.
4. Roediger WEW, Duncan A, Kapaniris O, Millard S. Reducing sulfur compounds of the colon impairs colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 1993;104:802-9.
5. Roediger WEW, Duncan A, Kapaniris O, Millard S. Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis? Clin Sci 1993;85:623-7.
6. Kitano A, Kobayashi K, Oshiumi H, Ookawa K, Oka S, Tanaka Y, et al. Studies of experimental ulcerative colitis induced by carrageenan in rabbits. Jpn J Gastroenterol 1981;78:2104-211.
7. Van De Waaji D, Cohen BJ, Anver MR. Mitigation of experimental inflammatory bowel disease in guinea pigs by selective elimination of the aerobic gram-negative intestinal microflora. Gastroenterology 1974;67:460-72.
8. Onderdonk AB, Hermos JA, Dzink JL, Bartlett JG. Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology 1978;74:521-6.
9. Onderdonk AB, Bartlett JG. Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr 1979;32:258-65.
10. Ohkusa T, Yamada M, Takenaga T, Kitazume C, Yamamoto N, Sasabe M, et al. Protective effect of metronidazole in experimental ulcerative colitis induced by dextran sulfate sodium. Jpn J Gastroenterol 1987;84:2337-46.
11. Magee EAM, Cummings JH. Fecal sulfide in the pathogen-esis and treatment of ulcerative colitis. Gastroenterology 1997;112:A891.
12. Roediger WEW, Moore J, Babidge W. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci 1997;42:1571-9.
13. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995;108:975-82.
14. Wang X, Gibson GR. Effects of in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 1993;75:373-80.
15. Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of colonic bacteria. J Appl Bacteriol 1994;77:412-20.
16. Beerens H. An elective and selective isolation medium for Bifidobacterium spp. Let Appl Microbiol 1990;11:155-7.
17. Postgate JR. The sulphate-reducing bacteria. 2nd ed. Cambridge: Cambridge University Press; 1984.
18. Florin THJ, Neale G, Gibson GR, Christi SU, Cummings JH. Metabolism of dietary sulphate: absorption and excretion in humans. Gut 1991;32:766-73.
19. Cline JD. Spectrophotometric determination of hydrogen sulfide in natural water. Limnol Oceanog 1969;14:454-8.
20. MacFarlane GT, Gibson GR. Sulphate reducing bacteria. In: Levett PN, editor. Anaerobic microbiology: a practical approach. Oxford: Oxford University Press; 1991. pp 201-22.
21. Spiller GA, Chernoff MC, Hill RA, Gates JE, Nassar JJ, Shipley EA. Effect of purified cellulose, pectin, and a low-residue diet on fecal volatile fatty acids, transit time, and fecal weight in humans. Am J Clin Nutr 1980;33:754-9.
22. Christi SU, Gibson GR, Cummings JH. Role of dietary sulphate in the regulation of methanogenesis in the human large intestine. Gut 1992;33:1234-8.
23. Pitcher MCL, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicyclic acid to faecal sulphide in patients with ulcerative colitis. Gut 2000;46:64-72.
24. Macfarlane GT, Cummings JH, Allison C. Protein degradation by human intestinal bacteria. J Gen Microbiol 1986;132:1647-56.
25. Magee EAM, Richardson CJ, Hughes R, Cummings JH. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr 2000;72:1488-94.
26. Bauer JH. Oral administration of radioactive sulphate to measure extracellular fluid space in man. J Appl Physiol 1976;40:648-50.
27. Moore JWE, Babidge W, Millard S, Roediger WEW. Colonic luminal hydrogen sulfide is not elevated in ulcerative colitis. Dig Dis Sci 1998;43:162-5.
28. Pitcher MCL, Beatty ER, Gibson GR, Cummings JH. Incidence and activities of sulphate-reducing bacteria in patients with ulcerative colitis. Gut 1995;36:A63.
29. El Oufir E, Flourié B, Varannes SB, Barry JL, Cloarec D, Bornet F, et al. Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans. Gut 1996;38:870-7.
30. Florin THJ, Khalil D, Lenarczyk A, Coweley DM. Sulfur metabolism in colons of carrageenan fed rats. J Gastroenterol Hepatol 1995;10:A56.
31. Levine J, Ellis CJ, Furne JK, Springfield J, Levitt MD. Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol 1998;93:83-7.
32. Chapman MAS, Grahn M, Boyle M, Hutton M, Rogers J, Williams NS. Butyrate metabolism is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 1994;35:73-6.
33. Roediger WEW. The colonic epithelium in ulcerative colitis: An energy-deficiency disease. Lancet 1980;ii:712-5.
34. Chapman RW, Selby WS, Jewel DP. Controlled trial of metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 1986;27:1210-2.
35. Gibson GR, Cummings JH, MacFarlane GT. Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Ecol 1991;86:103-12.
36. Hristova KR, Mau M, Zheng D, Aminov RI, Mackie RI, Gaskins HR, et al. Desulfotomaculum genus- and subgenus-specific 16S rRNA hybridization probes for environmental studies. Environ Microbiol 2000;2:143-59.
37. Zinkevich V, Beech IB. Screening of sulphate reducing bacteria in colonoscopy samples from healthy and colitic human gut mucosa. FEMS Microbiol Ecol 2000;34:147-55.
38. Zinkevich V, Kang H, Bogdarina I, Hill MA, Beech IB. The characterisation of exopolymers produced by different species of marine sulphate-reducing bacteria 1996;37:163-72.